Cargando…
Validation of The Hong Kong Liver Cancer Staging System in Patients with Hepatocellular Carcinoma after Curative Intent Treatment
BACKGROUNDS: Recently Hong Kong Liver Cancer (HKLC) staging system has been proposed for staging of hepatocellular carcinoma (HCC), and has been shown to provide better prognostic ability than the Barcelona Clinic Liver Cancer (BCLC) system. However, the HKLC system lacks external validation, and it...
Autores principales: | Chuncharunee, Alan, Siramolpiwat, Sith |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373815/ https://www.ncbi.nlm.nih.gov/pubmed/28670891 http://dx.doi.org/10.22034/APJCP.2017.18.6.1697 |
Ejemplares similares
-
Hepatocellular carcinoma staging systems: Hong Kong liver cancer vs Barcelona clinic liver cancer in a Western population
por: de Freitas, Laura Bainy Rodrigues, et al.
Publicado: (2019) -
Liver Transplantation for Hepatitis B Virus-related Hepatocellular Carcinoma in Hong Kong
por: Ma, Ka Wing, et al.
Publicado: (2018) -
Hong Kong Liver Cancer Staging System Is Associated With Better Performance for Hepatocellular Carcinoma: Special Emphasis on Viral Etiology
por: Liu, Po-Hong, et al.
Publicado: (2015) -
The prime time for management of hepatocellular carcinoma in Hong Kong
por: Chan, Landon L., et al.
Publicado: (2023) -
Barcelona Clinic Liver Cancer outperforms Hong Kong Liver Cancer staging of hepatocellular carcinoma in multiethnic Asians: Real-world perspective
por: Li, James Weiquan, et al.
Publicado: (2017)